
Simply hold the mid-infrared laser to your hand to measure blood sugar levels in just 5 seconds. This startup offers safe and convenient blood glucose monitoring that eliminates the need for blood sampling, reducing physical and mental burden while minimizing infection risks and medical waste.
[画像1: https://prtimes.jp/i/82314/9/resize/d82314-9-cd857c03a3cf744b5f3e-0.jpg ] 世界初の指で触れるだけで、採血なしに血糖値が測定できる非侵襲血糖値センサーの開発を行うライトタッチテクノロジー株式...
[画像1: https://prtimes.jp/i/82314/3/resize/d82314-3-e06dbe49872c4e5ed04e-0.jpg ] LTT社は糖尿病患者の方々の採血による血糖値測定に際する苦痛・ストレスの緩和、感染症リスクの低減、並びに糖尿病予備...
[画像1: https://prtimes.jp/i/82314/2/resize/d82314-2-1be3ad78c18aff849495-0.png ]   世界初の採血のいらない非侵襲血糖値センサーの開発を行うライトタッチテクノロジー(Light Touch Technology:...

A startup engaged in the design, manufacturing, and sales of measurement devices using laser-plasma technology. It provides high-precision measurement and analysis solutions, enhancing efficiency and sophistication in research, development, and industrial applications.

Luxana Biotech is a preclinical antisense oligonucleotide (ASO) development company based on proprietary nucleic acids with unique cross-linking structures. We have created the LuxiAP™ ASO drug discovery platform for the central nervous system and ophthalmic fields. The company has collaborative research agreements with multiple pharmaceutical companies and maintains its own ASO pipeline. We are seeking to expand partnership opportunities not only for collaborative research with pharmaceutical companies but also for joint development utilizing our proprietary pipeline.

Development and manufacturing of multifunctional photocatalytic coating agents and provision of related technologies.

Our core competence is NanoGAS® technology, which enables the long-term stabilization of nano-scale bubbles over several years. In the healthcare sector, we have leveraged this technology to develop a pioneering Fecal Microbiota Transplantation (FMT) technique. Its efficacy and safety have been validated through "Specific Clinical Research" regarding its impact on Autism Spectrum Disorder (ASD). Furthermore, we have established robust clinical evidence, including a 50% reduction in healing time for pressure ulcers and a 50% decrease in the volume of laxatives required for endoscopic procedures. Beyond medicine, NanoGAS® provides superior oxidation inhibition (anti-corrosion) and antibacterial effects. With a proven track record in maintaining the hygiene of humidifiers, our technology is available for licensing and joint development to dramatically enhance the value of products across diverse fields—from healthcare to industrial and HVAC infrastructure.